Results 81 to 90 of about 5,244 (166)

Successful anti-tumor effects with two novel bifunctional chemotherapeutic compounds that combine a LAT1 substrate with cytotoxic moieties in aggressive T-cell lymphomas

open access: yesLeukemia Research Reports
T-cell lymphomas are aggressive neoplasms characterized by poor responses to current chemotherapeutic agents. Expression of the l-type amino acid transporter 1 (LAT 1, SLC7A5) allows for the expansion of healthy T-cell counterparts, and upregulation of ...
Carlos Murga-Zamalloa   +10 more
doaj   +1 more source

Angioimmunoblastic T-cell lymphoma

open access: yesIndian Journal of Dermatology, Venereology, and Leprology, 2015
RashmiS Mahajan   +3 more
openaire   +2 more sources

Leukaemic relapse of angioimmunoblastic T‐cell lymphoma [PDF]

open access: yesBritish Journal of Haematology, 2020
Keir Pickard   +3 more
openaire   +3 more sources

Single-cell transcriptomic mapping of immune heterogeneity across angioimmunoblastic T-cell lymphoma subtypes. [PDF]

open access: yesBiomark Res
Liu H   +13 more
europepmc   +1 more source

Pioneering the future: nanotechnology's role in angioimmunoblastic T-cell lymphoma. [PDF]

open access: yesAnn Med Surg (Lond)
Anjum HM   +4 more
europepmc   +1 more source

Prognostic role of whole blood Epstein‑Barr virus DNA load in angioimmunoblastic T-cell lymphoma. [PDF]

open access: yesInfect Agent Cancer
Zhong Y   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy